ArticleOncotarget2017

Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.

Sung-Hsin Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.